AFL: Future Returns Will Reflect Mixed Carrier Tailwinds And Cautious Earnings Expectations

Aflac's updated fair value edges up by about $0.36 to roughly $112.43 as analysts factor in higher Street price targets that reflect stronger recent stock performance and generally firm Q1 underwriting and earnings trends across insurers.

Analyst Commentary

Recent Street research around Aflac shows a mix of optimism and caution, with several firms adjusting price targets in both directions as they reassess valuation and execution after first quarter results.

Bullish Takeaways

Bullish analysts who raised price targets point to recent stock performance as support for a higher fair value range, suggesting that the market has been rewarding Aflac's execution.
Some bullish analysts highlight generally firm first quarter underwriting and earnings trends across insurers, which they see as supportive for carriers like Aflac compared with insurance brokers.
One large investment bank describes first quarter results for life insurers as "generally strong" and points to earnings momentum tied to international business activity and improvements in mortality, which feeds into their higher price target for Aflac.
Analysts that favor carriers over brokers see underwriting performance as a key driver, and their higher targets for Aflac reflect a view that the company is positioned to participate in those sector level tailwinds.

Bearish Takeaways

Bearish analysts who recently lowered price targets are signaling that, at current levels, they see less room for upside on valuation, even if fundamentals remain solid.
Some cautious views suggest that earlier expectations for Aflac may have been too optimistic, prompting downward target revisions as analysts recalibrate their assumptions.
Where ratings remain more neutral, such as Equal Weight or Market Perform, analysts appear comfortable with Aflac's execution but less convinced that the risk or reward profile strongly favors either side at current prices.
The mix of both higher and lower targets across the Street underlines that, while Aflac's recent performance is reflected in several upgraded views, there is still debate about how much of that is already priced into the stock.

What's in the News

Morgan Stanley raised its Aflac price target to US$125 from US$120 with an Equal Weight rating, and Piper Sandler lifted its target to US$130 from US$125 with an Overweight rating, both citing confidence in steady business momentum and solid operational trends. (Source: recent analyst reports)
Aflac reported strong Q1 2026 results, with steady revenue, resilient earnings, and profitability supported by premium growth in the U.S. and Japan, higher investment income, and disciplined expenses, while analysts as a group hold a consensus Hold rating. (Source: Q1 2026 results coverage)
The company returned between US$1.0b and US$1.3b to shareholders in the first quarter through a mix of dividends and share repurchases, reinforcing its focus on cash returns. (Source: Q1 2026 results coverage)
From January 1 to March 31, 2026, Aflac repurchased 9,024,683 shares for US$1,000m, bringing cumulative buybacks under the August 8, 2017 program to 274,701,431 shares, or 43.25% of shares, for US$18,667.72m. (Source: buyback tranche update)
Aflac opened a fully staffed office in South Portland, Maine, to provide claims administration for over 500,000 eligible workers in the state's Paid Family and Medical Leave program, which begins issuing benefits as of May 1. (Source: business expansion announcement)

Valuation Changes

Fair Value has risen slightly, moving from about $112.07 to about $112.43 per share.
Discount Rate is effectively unchanged, holding around 7.11% in the updated model.
Revenue Growth assumptions remain essentially flat, staying at a slight decline of about 0.73% in each case.
Net Profit Margin is stable at roughly 20.50%, with only a very small technical adjustment in the updated figure.
Future P/E has risen slightly from about 16.61x to about 16.66x, reflecting a small upward shift in the earnings multiple applied.

3 views

Key Takeaways

Product innovation and digitalization expand Aflac's market reach, support topline growth, and improve operational efficiency and customer engagement.
Investment portfolio diversification and new distribution strategies enhance earnings stability and drive sustained long-term income growth.
Heavy reliance on Japan and challenging investment returns, along with weak U.S. sales growth, pose ongoing risks to Aflac's revenue, earnings, and margin stability.

Catalysts

About Aflac

Through its subsidiaries, provides supplemental health and life insurance products.What are the underlying business or industry changes driving this perspective?

The successful launch of new, customizable cancer insurance (Miraito) in Japan, coupled with strong early sales across all distribution channels-including banks and Japan Post-positions Aflac to capture growing demand for supplemental health coverage among aging and younger consumers, supporting topline revenue and premium growth.
Increased adoption of digital underwriting, customer-facing Gen AI, and digital human avatar initiatives in both Japan and the U.S. is expected to lower long-term operational costs and improve customer engagement, with the potential to materially expand net margins through enhanced efficiency and better scalability.
Heightened consumer awareness of financial health risks and rising medical costs-combined with product innovation (such as modular coverage, new children's cancer policies, and expanded group dental/vision)-broadens Aflac's addressable market and increases cross-sell opportunities, supporting both revenue and persistency.
Ongoing diversification and optimization of Aflac's investment portfolio, including the proactive management of yen
and USD-denominated assets, positions the company to better withstand interest rate cycles and enhance investment income stability, reducing earnings volatility and supporting sustainable bottom-line growth.
Strategic expansion in digital direct-to-consumer channels in the U.S., aggressive agent recruitment in Japan, and new partnerships with large institutions (like state-run disability leave programs) enable Aflac to extend market reach and drive sustained earned premium and fee-based income growth over the long term.

Aflac Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Aflac's revenue will remain fairly flat over the next 3 years.
Analysts assume that profit margins will shrink from 25.6% today to 20.5% in 3 years time.
Analysts expect earnings to reach $3.6 billion (and earnings per share of $8.01) by about June 2029, down from $4.6 billion today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 16.7x on those 2029 earnings, up from 12.7x today. This future PE is greater than the current PE for the US Insurance industry at 10.7x.
Analysts expect the number of shares outstanding to decline by 4.83% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.11%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

Net earned premiums in Japan, Aflac's largest and most profitable market, continued to decline year-over-year (down 1.1% excluding one-off effects), and management's guidance recognizes ongoing negative premium growth of -1% to -2% for the foreseeable future, which could constrain future revenue and earnings growth.
The company is experiencing increased technology and expense ratios in Japan (up 280 basis points year-over-year), largely due to digital transformation initiatives; if these investments do not translate into commensurate productivity gains, net margins may remain under pressure.
Aflac's significant exposure to Japan subjects it to persistent currency fluctuations and economic uncertainty-yen depreciation directly impacts reported USD earnings and the efficacy of capital deployment (including 65% of debt held in yen), increasing volatility in both reported revenue and earnings per share.
Variable net investment income was materially below long-term targets in the quarter (down 10.5% in yen terms for Japan), highlighting the ongoing risk from persistent low global bond yields and challenging investment environments, which could lead to lower investment returns and net margins over the long-term.
Persistent sluggishness in U.S. sales (only a 2.7% year-over-year increase), still not at historical growth rates, and dependence on agent recruitment and effectiveness in the traditional distribution channel, points to execution risk; failure to reinvigorate U.S. sales growth may limit future revenue expansion and earnings diversification.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $112.43 for Aflac based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $130.0, and the most bearish reporting a price target of just $99.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $17.7 billion, earnings will come to $3.6 billion, and it would be trading on a PE ratio of 16.7x, assuming you use a discount rate of 7.1%.
Given the current share price of $115.61, the analyst price target of $112.43 is 2.8% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Aflac?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

AFL: Earnings Stability And Strong Buybacks Will Support Balanced Outlook